Edition:
United States

Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.10USD
16 Feb 2018
Change (% chg)

$0.10 (+3.33%)
Prev Close
$3.00
Open
$3.00
Day's High
$3.10
Day's Low
$3.00
Volume
12,269
Avg. Vol
40,655
52-wk High
$5.40
52-wk Low
$2.25

Chart for

About

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage... (more)

Overall

Beta: 0.61
Market Cap(Mil.): $153.77
Shares Outstanding(Mil.): 51.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-COMPUGEN REPORTS Q3 LOSS PER SHARE $0.19

* ‍AS OF SEPTEMBER 30, 2017, CASH AND CASH RELATED ACCOUNTS TOTALED $38.5 MILLION, COMPARED WITH $61.5 MILLION AS OF DECEMBER 31, 2016​ Source text for Eikon: Further company coverage:

Nov 07 2017

BRIEF-Compugen to initiate manufacturing of COM902

* Compugen Ltd - ‍advancing COM902 into manufacturing in anticipation of filing an investigational new drug (IND) application in 2019​

Nov 06 2017

Earnings vs. Estimates